RPRD Diagnostics announced a collaboration with Children’s Minnesota dedicated to implementing a pharmaco-genomic testing process.
Jed Manocherian wants your attention—but not for himself.
RPRD Diagnostics, Children’s Minnesota to advance clinical pharmacogenomics
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Soon after real estate developer and investor Jed Manocherian started a non-profit that lobbies for biomedical research, he heard about the outsized role Mary Lasker played in shaping government-funded biomedical research in the U.S.
Mary Lasker left a collection of detailed oral histories and a massive archive of documents, kept at Columbia University: 795 boxes and 7 flat boxes, which amount to 353 linear feet.
NCI is on the cusp of releasing designs for its National Cancer Plan, an initiative that would guide the institute’s mission and portfolio for years to come and engage everyone in oncology to “end cancer as we know it,” said NCI Director Monica Bertagnolli.
The FDA Oncology Center of Excellence has signed on as the latest contributor to the Cancer History Project.
Patricia M. LoRusso was elected president-elect of the American Association for Cancer Research for 2023-2024.
